Study S003374

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Zovaglutide in Adults With Overweight or Obesity.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07230119
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 755
Start: 2026-01-16
Primary completion: 2027-05-29
Lead sponsor: Beijing QL Biopharmaceutical Co.,Ltd
Conditions: Overweight , Obesity
Interventions: DRUG:Zovaglutide dose 1; DRUG:Zovaglutide dose 2; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Change in body weight(%) [baseline (week 0) to week 52]
Proportion of subjects achieving ≥ 5% weight loss [52 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.